Erratum to “Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme” (Lung Cancer (2019) 134 (66–71), (S0169500219304702), (10.1016/j.lungcan.2019.05.026));Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme

Lung Cancer

Volumn 134, Issue , 2019, Pages 66-71

  Ghimire, Bhagabati ^a   Maroni, Roberta ^a   Vulkan, Daniel ^a   Shah, Zoheb ^a   Gaynor, Edward ^b   Timoney, Michelle ^b   Jones, Lisa ^b   Arvanitis, Rachel ^b   Ledson, Martin ^c   Lukehirst, Linda ^c   Rutherford, Paul ^c   Clarke, Faye ^c   Gardner, Katy ^b   Marcus, Michael W ^d   Hill, Sarah ^d   Fideo, Darcy ^d   Mason, Sabrina ^d   Smith, Samuel G ^e   Quaife, Samantha L ^f   Fitzgerald, Karen ^g   Poirier, Veronique ^g   Duffy, Stephen W ^a   Field, John K ^d   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g Cancer Research   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Early diagnosis; Health inequalities; Low dose CT; Lung cancer; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; EARLY CANCER DIAGNOSIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRAM EVALUATION; RISK ASSESSMENT; RISK REDUCTION; SMOKING; SMOKING CESSATION; SOCIAL STATUS; SPIROMETRY; UNITED KINGDOM; X-RAY COMPUTED TOMOGRAPHY; COMMUNITY CARE; HEALTH CARE DISPARITY; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; PROCEDURES; RISK FACTOR;

AGED; COMMUNITY HEALTH SERVICES; EARLY DETECTION OF CANCER; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; UNITED KINGDOM;

EID: 85066743199     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2019.10.007     Document Type: Erratum

References (44)

1. Lung cancer statistics, Cancer Research UK, https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer#heading-Two (n.d.). (Accessed 17 July 2018).
2. Quaresma, M., Coleman, M.P., Rachet, B., 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: A population-based study. Lancet 385 (2015), 1206–1218, 10.1016/S0140-6736(14)61396-9.
3. W.C. Services, N. Awareness, K. Collins, W.C. Services, Early detection and awareness of lung cancer Project details, n.d.
4. De Angelis, R., Sant, M., Coleman, M.P., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O., Brenner, H., Ardanaz, E., Bielska-Lasota, M., Engholm, G., Nennecke, A., Siesling, S., Berrino, F., Capocaccia, R., Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol. 2045 (2013), 1–12, 10.1016/S1470-2045(13)70546-1.
5. Lung and Bronchus Cancer - Cancer Stat Facts, https://seer.cancer.gov/statfacts/html/lungb.html (n.d.). (Accessed 16 July 2018).
6. Coureau, G., Salmi, L.R., Etard, C., Sancho-Garnier, H., Sauvaget, C., Mathoulin-Pélissier, S., Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: a systematic methodological appraisal of published randomised controlled trials. Eur. J. Cancer, 2016, 10.1016/j.ejca.2016.04.006.
7. Sone, S., Li, F., Yang, Z.G., Honda, T., Maruyama, Y., Takashima, S., Hasegawa, M., Kawakami, S., Kubo, K., Haniuda, M., Yamanda, T., Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br. J. Cancer 84 (2001), 25–32, 10.1054/bjoc.2000.1531.
8. Blanchon, T., Bréchot, J.M., Grenier, P.A., Ferretti, G.R., Lemarié, E., Milleron, B., Chagué, D., Laurent, F., Martinet, Y., Beigelman-Aubry, C., Blanchon, F., Revel, M.P., Friard, S., Rémy-Jardin, M., Vasile, M., Santelmo, N., Lecalier, A., Lefébure, P., Moro-Sibilot, D., Breton, J.L., Carette, M.F., Brambilla, C., Fournel, F., Kieffer, A., Frija, G., Flahault, A., Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 58 (2007), 50–58, 10.1016/j.lungcan.2007.05.009.
9. T.N.L.S.T.R. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., Berg, C.D., Black, W.C., Clapp, J.D., Fagerstrom, R.M., Gareen, I.F., Gatsonis, C., Marcus, P.M., Sicks, J.D., Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365 (2011), 395–409, 10.1056/NEJMoa1102873.
10. Burns, D.M., Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention. Cancer Epidemiol. Biomarkers Prev. 89 (2000), 2506–2509, 10.1002/1097-0142(20001201)89:11+<2506::AID-CNCR33>3.3.CO;2-# [pii].
11. Noone, A., Howlader, N., Krapcho, M., Miller, D., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D., Chen, H., Feuer, E., Cronin, K., SEER Cancer Statistics Review, 1975-2015. 2018, National Cancer Institute Based Novemb. 2017 SEER Data Submission, Posted to SEER Web Site, April 2018. 2015.
12. J.P. Pierce, K. Messer, D.W. Cowling, D.P. Thomas, and the United States, 1965-2007, 305 (2011).
13. Woods, L.M., Rachet, B., Coleman, M.P., Origins of socio-economic inequalities in cancer survival: a review. Ann. Oncol. 17 (2006), 5–19, 10.1093/annonc/mdj007.
14. Riaz, S.P., Horton, M., Kang, J., Mak, V., Lüchtenborg, M., Møller, H., Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J. Thorac. Oncol. 6 (2011), 2005–2010, 10.1097/JTO.0b013e31822b02db.
15. Lyratzopoulos, G., Barbiere, J.M., Rachet, B., Baum, M., Thompson, M.R., Coleman, M.P., Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): The potential role of health care. Ann. Oncol., 2011, 10.1093/annonc/mdq647.
16. Coleman, M.P., Rachet, B., Woods, L.M., Mitry, E., Riga, M., Cooper, N., Quinn, M.J., Brenner, H., Estève, J., Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br. J. Cancer 90 (2004), 1367–1373, 10.1038/sj.bjc.6601696.
17. Berglund, A., Lambe, M., Lüchtenborg, M., Linklater, K., Peake, M.D., Holmberg, L., Møller, H., Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open, 2, 2012, 10.1136/bmjopen-2012-001048.
18. Jack, R.H., Gulliford, M.C., Ferguson, J., Møller, H., Geographical inequalities in lung cancer management and survival in South East England: Evidence of variation in access to oncology services?. Br. J. Cancer 88 (2003), 1025–1031, 10.1038/sj.bjc.6600831.
19. National Cancer Registration and Analysis Service, Cancer by Deprivation in England 1996-2011, http://www.ncin.org.uk/about_ncin/cancer_by_deprivation_in_england (n.d.). (accessed July 20, 2018).
20. British Lung Foundation, The Battle for Breath Report - The Impact of Lung Disease in the UK., 2015, 10.1109/TE.2008.917191.
21. Cassidy, A., Myles, J.P., Van Tongeren, M., Page, R.D., Liloglou, T., Duffy, S.W., Field, J.K., The LLP risk model: an individual risk prediction model for lung cancer. Br. J. Cancer 98 (2008), 270–276, 10.1038/sj.bjc.6604158.
22. Lung cancer survival statistics, Cancer Research UK https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/survival (n.d.). (Accessed 17 July 2018).
23. Saghir, Z., Dirksen, A., Ashraf, H., Bach, K.S., Brodersen, J., Clementsen, P.F., Døssing, M., Hansen, H., Kofoed, K.F., Larsen, K.R., Mortensen, J., Rasmussen, J.F., Seersholm, N., Skov, B.G., Thorsen, H., Tønnesen, P., Pedersen, J.H., CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 67 (2012), 296–301, 10.1136/thoraxjnl-2011-200736.
24. Wille, M.M.W., Dirksen, A., Ashraf, H., Saghir, Z., Bach, K.S., Brodersen, J., Clementsen, P.F., Hansen, H., Larsen, K.R., Mortensen, J., Rasmussen, J.F., Seersholm, N., Skov, B.G., Thomsen, L.H., Tønnesen, P., Pedersen, J.H., Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am. J. Respir. Crit. Care Med. 193 (2016), 542–551, 10.1164/rccm.201505-1040OC.
25. Hestbech, M.S., Siersma, V., Dirksen, A., Pedersen, J.H., Brodersen, J., Participation bias in a randomised trial of screening for lung cancer. Lung Cancer 73 (2011), 325–331, 10.1016/j.lungcan.2010.12.018.
26. T.N.L.S.T.R.T.W. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., Berg, C.D., Clapp, J.D., Clingan, K.L., Gareen, I.F., Lynch, D.A., Marcus, P.M., Pinsky, P.F., Baseline characteristics of participants in the randomized national lung screening trial. J. Natl. Cancer Inst. 102 (2010), 1771–1779, 10.1093/jnci/djq434.
27. Yousaf-Khan, U., Horeweg, N., van der Aalst, C., Ten Haaf, K., Oudkerk, M., de Koning, H., Baseline characteristics and mortality outcomes of control group participants and eligible non-responders in the NELSON lung cancer screening study. J. Thorac. Oncol. 10 (2015), 747–753, 10.1097/JTO.0000000000000488.
28. McRonald, F.E., Yadegarfar, G., Baldwin, D.R., Devaraj, A., Brain, K.E., Eisen, T., Holemans, J.A., Ledson, M., Screaton, N., Rintoul, R.C., Hands, C.J., Lifford, K., Whynes, D., Kerr, K.M., Page, R., Parmar, M., Wald, N., Weller, D., Williamson, P.R., Myles, J., Hansell, D.M., Duffy, S.W., Field, J.K., The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev. Res. (Phila) 7 (2014), 362–371, 10.1158/1940-6207.CAPR-13-0206.
29. Quaife, S.L., Marlow, L.A.V., McEwen, A., Janes, S.M., Wardle, J., Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication. Health Expect. 20 (2017), 563–573, 10.1111/hex.12481.
30. Quaife, S.L., Vrinten, C., Ruparel, M., Janes, S.M., Beeken, R.J., Waller, J., McEwen, A., Smokers’ interest in a lung cancer screening programme: a national survey in England. BMC Cancer, 18, 2018, 497, 10.1186/s12885-018-4430-6.
31. Smits, S.E., McCutchan, G.M., Hanson, J.A., Brain, K.E., Attitudes towards lung cancer screening in a population sample. Health Expect., 2018, 10.1111/hex.12819.
32. Carter-Harris, L., Brandzel, S., Wernli, K.J., Roth, J.A., Buist, D.S.M., A qualitative study exploring why individuals opt out of lung cancer screening. Fam. Pract., 34, 2017, 10.1093/fampra/cmw146 cmw146.
33. Ali, N., Lifford, K.J., Carter, B., McRonald, F., Yadegarfar, G., Baldwin, D.R., Weller, D., Hansell, D.M., Duffy, S.W., Field, J.K., Brain, K., Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer screening (UKLS) trial. BMJ Open, 5, 2015, e008254, 10.1136/bmjopen-2015-008254.
34. Adult smoking habits in the UK: 2015, (n.d.). https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/adultsmokinghabitsingreatbritain/2015.
35. Stringhini, S., Sabia, S., Shipley, M., Brunner, E., Nabi, H., Kivimaki, M., Singh-Manoux, A., Association of socioeconomic position with health behaviors and mortality. JAMA 303 (2010), 1159–1166, 10.1001/jama.2010.297.
36. What are the health risks of smoking? NHS UK, https://www.nhs.uk/common-health-questions/lifestyle/what-are-the-health-risks-of-smoking/ (n.d.) (Accessed 18 July 2018).
37. British Lung foundation, Briefing: health inequalities and lung disease, https://www.blf.org.uk/sites/default/files/BritishLung Foundation-Lung disease and health inequalities briefing.pdf (n.d.). (Accessed 19 July 2018).
38. Health and Social Care Information centre, Statistics on Smoking England, 2016. 2016 (Accessed 19 July 2018) http://www.statisticsauthority.gov.uk/assessment/code-of-practice.
39. Guirguis-Blake, J.M., Senger, C.A., Webber, E.M., Mularski, R.A., Whitlock, E.P., Screening for chronic obstructive pulmonary disease. JAMA, 315, 2016, 1378, 10.1001/jama.2016.2654.
40. Field, J.K., Duffy, S.W., Baldwin, D.R., Whynes, D.K., Devaraj, A., Brain, K.E., Eisen, T., Gosney, J., Green, B.A., Holemans, J.A., Kavanagh, T., Kerr, K.M., Ledson, M., Lifford, K.J., McRonald, F.E., Nair, A., Page, R.D., Parmar, M.K.B., Rassl, D.M., Rintoul, R.C., Screaton, N.J., Wald, N.J., Weller, D., Williamson, P.R., Yadegarfar, G., Hansell, D.M., UK Lung Cancer RCT Pilot screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71 (2016), 161–170, 10.1136/thoraxjnl-2015-207140.
41. Callister, M.E.J., Baldwin, D.R., Akram, A.R., et al. BTS guidelines for the investigation and management of pulmonary nodules. Thorax 70 (2015), ii1–ii54.
42. Crosbie, P.A., Balata, H., Evison, M., Atack, M., Bayliss-Brideaux, V., Colligan, D., Duerden, R., Eaglesfield, J., Edwards, T., Elton, P., Foster, J., Greaves, M., Hayler, G., Higgins, C., Howells, J., Irion, K., Karunaratne, D., Kelly, J., King, Z., Manson, S., Mellor, S., Miller, D., Myerscough, A., Newton, T., O'Leary, M., Pearson, R., Pickford, J., Sawyer, R., Screaton, N.J., Sharman, A., Simmons, M., Smith, E., Taylor, B., Taylor, S., Walsham, A., Watts, A., Whittaker, J., Yarnell, L., Threlfall, A., Barber, P.V., Tonge, J., Booton, R., Implementing lung cancer screening: baseline results from a community-based “Lung Health Check” pilot in deprived areas of Manchester. Thorax, 2018, 10.1136/thoraxjnl-2017-211377 thoraxjnl-2017-211377.
43. Van der Aalst, C.M., van den Bergh, K.A.M., Willemsen, M.C., de Koning, H.J., van Klaveren, R.J., Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 65 (2010), 600–605, 10.1136/thx.2009.133751.
44. De Koning, H., Van Der Aalst, C., Ten Haaf, K., Oudkerk, M., Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial, in: IASLC 19th World Conf. Lung Cancer, 2018, 10.1016/j.jtho.2018.08.012.